Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Price to Sales HistoryNormalizing
Percentile Rank67
3Y CAGR-1.5%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-1.5%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20254.52+35.3%
20243.34-26.6%
20234.55-3.7%
20224.72-77.5%
202120.94-
20200.00-
20190.00-
20180.00-
20170.00-
20160.00-